News
Medical Device Network on MSN7h
FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’sThe US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting signs and symptoms of the condition.
U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback